Galectin 1 decreases risk of Nephropathy in Diabetics
Researchers at the University of Gothenburg now associate elevated levels of the protein galectin-1 with increased risk of developing type 2 diabetes about 18 years later. At the same time, this protein seems to be a protective factor for the kidneys among type 2 diabetes patients at high risk for diabetic nephropathy.
Findings of the study, a collaboration with researchers at Lund University, have been published in the journal Diabetologia. The researchers point to both negative and positive links between the protein galectin-1 and type 2 diabetes. In a general population, galectin-1 may be associated with an increased risk of diabetes, but in patients with a subtype of diabetes that increases the risk of kidney damage, galectin-1 appears to be beneficial, as patients with high galectin-1 levels in their blood suffer less kidney damage.
For more details, check out the full story on the link below:
Galectin-1 Increases Risk Of Developing Type 2 Diabetes, Decreases Risk Of Nephropathy In Diabetics
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.